Breaking News, Collaborations & Alliances

Calvert, Oncoceutics in Preclincial Research Pact

Will complete testing of ONC201 for IND filing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Calvert Research, LLC and Oncoceutics, Inc. have entered an investment partnership agreement to support completion of preclinical studies for Oncoceutics’ anti-cancer compound ONC201. Calvert Research’s CRO affiliate, Calvert Laboratories will complete animal pharmacology, toxicology, and pharmacokinetic testing and conduct bioanalytical studies for ONC201 to support the filing of an IND application with the FDA by the end of 2013. Calvert Research has also made a significant investment in...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters